Strides Pharma Science reports standalone net profit of Rs 47.00 crore in the September 2019 quarter
Sales rise 25.70% to Rs 425.41 crore
Net profit of Strides Pharma Science reported to Rs 47.00 crore in the quarter ended September 2019 as against net loss of Rs 14.30 crore during the previous quarter ended September 2018. Sales rose 25.70% to Rs 425.41 crore in the quarter ended September 2019 as against Rs 338.43 crore during the previous quarter ended September 2018. ParticularsQuarter EndedSep. 2019Sep. 2018% Var.Sales425.41338.43 26 OPM %14.95-1.00 -PBDT80.915.62 1340 PBT58.22-15.61 LP NP47.00-14.30 LPPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content